Literature DB >> 28241198

Using the National Cancer Database for Outcomes Research: A Review.

Daniel J Boffa1, Joshua E Rosen1, Katherine Mallin2, Ashley Loomis2, Greer Gay2, Bryan Palis2, Kathleen Thoburn2, Donna Gress3, Daniel P McKellar2, Lawrence N Shulman2,4, Matthew A Facktor2, David P Winchester2,5.   

Abstract

Importance: The National Cancer Database (NCDB), a joint quality improvement initiative of the American College of Surgeons Commission on Cancer and the American Cancer Society, has created a shared research file that has changed the study of cancer care in the United States. A thorough understanding of the nuances, strengths, and limitations of the database by both readers and investigators is of critical importance. This review describes the use of the NCDB to study cancer care, with a focus on the advantages of using the database and important considerations that affect the interpretation of NCDB studies. Observations: The NCDB is one of the largest cancer registries in the world and has rapidly become one of the most commonly used data resources to study the care of cancer in the United States. The NCDB paints a comprehensive picture of cancer care, including a number of less commonly available details that enable subtle nuances of treatment to be studied. On the other hand, several potentially important patient and treatment attributes are not collected in the NCDB, which may affect the extent to which comparisons can be adjusted. Finally, the NCDB has undergone several significant changes during the past decade that may affect its completeness and the types of available data. Conclusions and Relevance: The NCDB offers a critically important perspective on cancer care in the United States. To capitalize on its strengths and adjust for its limitations, investigators and their audiences should familiarize themselves with the advantages and shortcomings of the NCDB, as well as its evolution over time.

Entities:  

Mesh:

Year:  2017        PMID: 28241198     DOI: 10.1001/jamaoncol.2016.6905

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


  224 in total

1.  Characteristics and overall survival in pediatric versus adult skull base chordoma: a population-based study.

Authors:  Jordan C Xu; Brandon M Lehrich; Tyler M Yasaka; Brendan M Fong; Frank P K Hsu; Edward C Kuan
Journal:  Childs Nerv Syst       Date:  2021-01-18       Impact factor: 1.475

2.  Racial Disparities in Treatment Patterns and Survival Among Surgically Treated Malignant Pleural Mesothelioma Patients.

Authors:  Naomi Alpert; Maaike van Gerwen; Meredith Steinberg; Nisha Ohri; Raja Flores; Emanuela Taioli
Journal:  J Immigr Minor Health       Date:  2020-12

3.  Potential Consequences of Minimum-Volume Standards for Hospitals Treating Women With Ovarian Cancer.

Authors:  Jason D Wright; Yongmei Huang; Alexander Melamed; Ana I Tergas; Caryn M St Clair; June Y Hou; Fady Khoury-Collado; Cande V Ananth; Alfred I Neugut; Dawn L Hershman
Journal:  Obstet Gynecol       Date:  2019-06       Impact factor: 7.661

4.  Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival.

Authors:  Andrew T Lenis; Claire S Burton; Vishnukamal Golla; Aydin Pooli; Izak Faiena; David C Johnson; Amirali Salmasi; Alexandra Drakaki; Kiran Gollapudi; Jeremy Blumberg; Allan J Pantuck; Karim Chamie
Journal:  Urol Oncol       Date:  2019-03-28       Impact factor: 3.498

5.  Survival after neoadjuvant approaches to gastroesophageal junction cancer.

Authors:  Michael Xiang; Daniel T Chang; Gregory M Heestand; Erqi L Pollom
Journal:  Gastric Cancer       Date:  2019-06-22       Impact factor: 7.370

6.  Outcomes After Resection of Hepatocellular Carcinoma: Intersection of Travel Distance and Hospital Volume.

Authors:  Eliza W Beal; Rittal Mehta; Katiuscha Merath; Diamantis I Tsilimigras; J Madison Hyer; Anghela Paredes; Mary E Dillhoff; Jordan Cloyd; Aslam Ejaz; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2019-05-08       Impact factor: 3.452

7.  Prognostic factors of survival in patients with malignant pleural mesothelioma: an analysis of the National Cancer Database.

Authors:  Maaike Van Gerwen; Naomi Alpert; Andrea Wolf; Nisha Ohri; Erik Lewis; Kenneth E Rosenzweig; Raja Flores; Emanuela Taioli
Journal:  Carcinogenesis       Date:  2019-06-10       Impact factor: 4.944

8.  Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy.

Authors:  Izak Faiena; Amirali Salmasi; Neil Mendhiratta; Andrew T Lenis; Aydin Pooli; Alexandra Drakaki; Kiran Gollapudi; Jeremy Blumberg; Allan J Pantuck; Karim Chamie
Journal:  World J Urol       Date:  2018-05-11       Impact factor: 4.226

9.  Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?

Authors:  Alexander L Lazarides; David L Kerr; Daniel P Nussbaum; R Timothy Kreulen; Jason A Somarelli; Dan G Blazer; Brian E Brigman; William C Eward
Journal:  Clin Orthop Relat Res       Date:  2019-04       Impact factor: 4.176

10.  Natural History and Treatment Trends in Pancreatic Cancer Subtypes.

Authors:  Courtney J Pokrzywa; Daniel E Abbott; Kristina A Matkowskyj; Sean M Ronnekleiv-Kelly; Emily R Winslow; Sharon M Weber; Alexander V Fisher
Journal:  J Gastrointest Surg       Date:  2019-01-31       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.